Cardiovascular Renal Metabolic

AHA 25: HFpEF as an Adipose Tissue Disorder

Milton Packer

Watch time: 5m 43s
AHA 25: Pregnancy and CKM Health: Essential Knowledge for Cardiologists

Emily Lau

Watch time: 7m 24s
AHA 25 Late-breaking Discussion: Analysis from the SURPASS-CVOT Trial

Harriette Van Spall, Stephen Nicholls

Watch time: 12m 43s
AHA 25: The CORALreef HeFH Trial

Christie Ballantyne

Watch time: 5m 9s
AHA 2025: The TIRZSEMA-CVOT Study

Nils Krüger

Watch time: 5m 49s
AHA 25: Lp(a) and ASCVD: Translating Causal Evidence into Clinical Practice

Michelle O'Donoghue

Watch time: 5m 1s

Nicolas M Van Mieghem

Watch time: 14m 12s (23 videos)

Christopher Henry Grant, Samira Bell

Read time: 19m 2s

Nir Uriel

Watch time: 34m 39s (5 videos)
HFSA 25: Sex-Specific Outcomes of Tirzepatide in Obesity-Related HFpEF

Barry Borlaug

Watch time: 7m 15s
EASD 25: Prespecified Analysis of CONFIDENCE

Rajiv Agarwal

Watch time: 7m 31s
Obesity in Focus: Implications for Heart Failure, Kidney Disease, and Pharmacology

Chim C Lang, Bianca Rocca, Samira Bell, et al

Watch time: 14m 14s

Andrew JS Coats, Stefan Anker

Nicolas M Van Mieghem

Watch time: 14m 12s (23 videos)

Paola Fioretto, Rajiv Agarwal

Watch time: 28m 13s (3 videos)
AHA 25: The CORALreef HeFH Trial

Christie Ballantyne

Watch time: 5m 9s
AHA 25: Lp(a) and ASCVD: Translating Causal Evidence into Clinical Practice

Michelle O'Donoghue

Watch time: 5m 1s
AHA 2025: The TIRZSEMA-CVOT Study

Nils Krüger

Watch time: 5m 49s

Christopher Henry Grant, Samira Bell

Read time: 19m 2s
AHA 25: Pregnancy and CKM Health: Essential Knowledge for Cardiologists

Emily Lau

Watch time: 7m 24s
AHA 25 Late-breaking Discussion: Analysis from the SURPASS-CVOT Trial

Harriette Van Spall, Stephen Nicholls

Watch time: 12m 43s
AHA 25: HFpEF as an Adipose Tissue Disorder

Milton Packer

Watch time: 5m 43s

Martin Berger, Nikolaus Marx, Katharina Marx-Schütt

Read time: 16m 8s

Stefan Anker, Shelley Zieroth, Andrew JS Coats, et al

Watch time: 5h 14m 55s (31 videos)

Media

AHA 23: Preventive Cardiology in 2023

Michael Honigberg

Watch time: 7m 3s
AHA 23: 3 Trials That Will Change My Practice

Dipti Itchhaporia

Watch time: 7m 20s
AHA 23 Late-Breaker Discussion: The SELECT Trial

A Michael Lincoff , Harriette Van Spall

Watch time: 21m 35s
CardioNerds @AHA23: Presidential Advisory on CKM Health

Ramy Doss, Chiadi Ndumele

Watch time: 14m 32s
ESC 23 Late-Breaker Discussion: The STEP HFpEF Trial

Harriette Van Spall, Mikhail Kosiborod

Watch time: 13m 24s
ESC 23: Day 1 Wrap-Up with Dr Alasnag and Dr Al-Shaibi

Mirvat Alasnag, Khaled Al-Shaibi

Watch time: 13m 28s
ERA 23: REVEAL-CKD: Underdiagnosis of CKD

Navdeep Tangri

Watch time: 3m 32s
ECO 23: Impact of Obesity on Heart Failure Outcomes

Laura Meems

Watch time: 7m 7s

James Burton, Shelley Zieroth, Clara Bonanad Lozano, et al

Watch time: 1h 34m (7 videos)

Fausto J Pinto, John Spertus, , et al

Obesity Management Strategies in 2023

Harold Bays

Watch time: 17m 7s
ACC 23 Late-breaking Discussion: The COORDINATE-Diabetes Trial

Harriette Van Spall, Neha Pagidipati, Christopher B Granger, et al

Watch time: 17m 32s

Media

AHA 25: The CORALreef HeFH Trial

Christie Ballantyne

Watch time: 5m 9s
AHA 25: HFpEF as an Adipose Tissue Disorder

Milton Packer

Watch time: 5m 43s

Nicolas M Van Mieghem

Watch time: 14m 12s (23 videos)
AHA 2025: The TIRZSEMA-CVOT Study

Nils Krüger

Watch time: 5m 49s
AHA 25: Pregnancy and CKM Health: Essential Knowledge for Cardiologists

Emily Lau

Watch time: 7m 24s
AHA 25: Lp(a) and ASCVD: Translating Causal Evidence into Clinical Practice

Michelle O'Donoghue

Watch time: 5m 1s
AHA 25 Late-breaking Discussion: Analysis from the SURPASS-CVOT Trial

Harriette Van Spall, Stephen Nicholls

Watch time: 12m 43s

Broadcast

Cardiovascular Renal Metabolic

Heart Failure
Managing Hyperkalaemia: Getting Patients to Optimal RAASi Therapy

James Burton, Clara Bonanad Lozano, Aaron Wong, et al

Watch time: 1h 3m 30s

Broadcast

Cardiovascular Renal Metabolic

Prevention & Chronic Conditions
Managing Hypertension in CVD: How Low Can We Go?

Yassir Javaid, Michel Burnier, Mariya Tokmakova, et al

Watch time: 57m 24s

Broadcast

Cardiovascular Renal Metabolic

Prevention & Chronic Conditions
Advancements in Obesity Management (AOM) 2025

Harold Bays, Naveed Sattar, Liesbeth van Rossum, et al

Broadcast

Prevention & Chronic Conditions

Cardiovascular Renal Metabolic
AOM 2024

Harold Bays, Naveed Sattar, Mikhail Kosiborod, et al

Broadcast

Heart Failure

Prevention & Chronic Conditions
e-SPACE CRM 2024 - Day 2

Antonio Ceriello, Ileana L Piña, Gianluigi Savarese, et al

Articles

Anaemia in Patients with Diabetic Nephropathy - Prevalence, Causes and Clinical Consequences

Cristoph Hasslacher

,

Citation:

European Cardiovascular Disease 2007;3(1):80–2

DOI:

https://doi.org/10.15420/ecr.2007.0.1.80
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 514
  • Downloads: Downloads 6
  • Citations: 1

Drug-eluting Stents in Diabetic Patients

Julinda Mehilli

,

Gjin Ndrepepa

,

Citation:

European Cardiovascular Disease 2006;2(2):50–3

DOI:

https://doi.org/10.15420/ecr.2006.0.2.50
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 700
  • Downloads: Downloads 6

Management of the Asymptomatic Diabetic Patient with Evidence of Ischemia

Dimitrios Bliagos

,

Ajay J Kirtane

,

Jeffrey W Moses

,

Citation:

European Cardiology 2010;6(1):62–4

DOI:

https://doi.org/10.15420/ecr.2010.6.1.62
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 57
  • Downloads: Downloads 1

Hypertension and Diabetes Mellitus

Gurushankar Govindarajan

,

James R Sowers

,

Craig S Stump

,

Citation:

European Cardiovascular Disease 2006;2(1):21–4

DOI:

https://doi.org/10.15420/ecr.2006.1.21
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 721
  • Downloads: Downloads 14
  • Citations: 4